Epigenetic regulation and fetal programming

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Fetal programming encompasses the role of developmental plasticity in response to environmental and nutritional signals during early life and its potential adverse consequences (risk of cardiovascular, metabolic and behavioural diseases) in later life. The first studies in this field highlighted an association between poor fetal growth and chronic adult diseases. However, environmental signals during early life may lead to adverse long-term effects independently of obvious effects on fetal growth. Adverse long-term effects reflect a mismatch between early (fetal and neonatal) environmental conditions and the conditions that the individual will confront later in life. The mechanisms underlying this risk remain unclear. However, experimental data in rodents and recent observations in humans suggest that epigenetic changes in regulatory genes and growth-related genes play a significant role in fetal programming. Improvements in our understanding of the biochemical and molecular mechanisms at play in fetal programming would make it possible to identify biomarkers for detecting infants at high risk of adult-onset diseases. Such improvements should also lead to the development of preventive and therapeutic strategies.

Original languageEnglish
Pages (from-to)1-16
Number of pages16
JournalBest Practice and Research in Clinical Endocrinology and Metabolism
Volume22
Issue number1
DOIs
Publication statusPublished - 1 Feb 2008
Externally publishedYes

Keywords

  • developmental plasticity
  • epigenetics
  • fetal environment
  • fetal growth
  • fetal programming
  • genomic imprinting
  • metabolic programming

Cite this

@article{14f5fa5632584e3e99eb4e5b72d64651,
title = "Epigenetic regulation and fetal programming",
abstract = "Fetal programming encompasses the role of developmental plasticity in response to environmental and nutritional signals during early life and its potential adverse consequences (risk of cardiovascular, metabolic and behavioural diseases) in later life. The first studies in this field highlighted an association between poor fetal growth and chronic adult diseases. However, environmental signals during early life may lead to adverse long-term effects independently of obvious effects on fetal growth. Adverse long-term effects reflect a mismatch between early (fetal and neonatal) environmental conditions and the conditions that the individual will confront later in life. The mechanisms underlying this risk remain unclear. However, experimental data in rodents and recent observations in humans suggest that epigenetic changes in regulatory genes and growth-related genes play a significant role in fetal programming. Improvements in our understanding of the biochemical and molecular mechanisms at play in fetal programming would make it possible to identify biomarkers for detecting infants at high risk of adult-onset diseases. Such improvements should also lead to the development of preventive and therapeutic strategies.",
keywords = "developmental plasticity, epigenetics, fetal environment, fetal growth, fetal programming, genomic imprinting, metabolic programming",
author = "Christine Gicquel and Assam El-Osta and {Le Bouc}, Yves",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.beem.2007.07.009",
language = "English",
volume = "22",
pages = "1--16",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Elsevier",
number = "1",

}

Epigenetic regulation and fetal programming. / Gicquel, Christine; El-Osta, Assam; Le Bouc, Yves.

In: Best Practice and Research in Clinical Endocrinology and Metabolism, Vol. 22, No. 1, 01.02.2008, p. 1-16.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Epigenetic regulation and fetal programming

AU - Gicquel, Christine

AU - El-Osta, Assam

AU - Le Bouc, Yves

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Fetal programming encompasses the role of developmental plasticity in response to environmental and nutritional signals during early life and its potential adverse consequences (risk of cardiovascular, metabolic and behavioural diseases) in later life. The first studies in this field highlighted an association between poor fetal growth and chronic adult diseases. However, environmental signals during early life may lead to adverse long-term effects independently of obvious effects on fetal growth. Adverse long-term effects reflect a mismatch between early (fetal and neonatal) environmental conditions and the conditions that the individual will confront later in life. The mechanisms underlying this risk remain unclear. However, experimental data in rodents and recent observations in humans suggest that epigenetic changes in regulatory genes and growth-related genes play a significant role in fetal programming. Improvements in our understanding of the biochemical and molecular mechanisms at play in fetal programming would make it possible to identify biomarkers for detecting infants at high risk of adult-onset diseases. Such improvements should also lead to the development of preventive and therapeutic strategies.

AB - Fetal programming encompasses the role of developmental plasticity in response to environmental and nutritional signals during early life and its potential adverse consequences (risk of cardiovascular, metabolic and behavioural diseases) in later life. The first studies in this field highlighted an association between poor fetal growth and chronic adult diseases. However, environmental signals during early life may lead to adverse long-term effects independently of obvious effects on fetal growth. Adverse long-term effects reflect a mismatch between early (fetal and neonatal) environmental conditions and the conditions that the individual will confront later in life. The mechanisms underlying this risk remain unclear. However, experimental data in rodents and recent observations in humans suggest that epigenetic changes in regulatory genes and growth-related genes play a significant role in fetal programming. Improvements in our understanding of the biochemical and molecular mechanisms at play in fetal programming would make it possible to identify biomarkers for detecting infants at high risk of adult-onset diseases. Such improvements should also lead to the development of preventive and therapeutic strategies.

KW - developmental plasticity

KW - epigenetics

KW - fetal environment

KW - fetal growth

KW - fetal programming

KW - genomic imprinting

KW - metabolic programming

UR - http://www.scopus.com/inward/record.url?scp=38949154428&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2007.07.009

DO - 10.1016/j.beem.2007.07.009

M3 - Review Article

VL - 22

SP - 1

EP - 16

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 1

ER -